cheaptrix/UnitedStatesSenateBillsAndSummaries huggingface dataset:
Transnational Drug Trafficking Act of 2015

To provide the Department of Justice with additional tools to target extraterritorial drug trafficking activity, and for other purposes. 1. Short title This Act may be cited as the Transnational Drug Trafficking Act of 2015 2. Possession, manufacture or distribution for purposes of unlawful importations Section 1009 of the Controlled Substances Import and Export Act ( 21 U.S.C. 959 (1) by redesignating subsections (b) and (c) as subsections (c) and (d), respectively; and (2) in subsection (a), by striking It shall (b) It shall be unlawful for any person to manufacture or distribute a listed chemical— (1) intending or knowing that the listed chemical will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the controlled substance will be unlawfully imported into the United States. . 3. Trafficking in counterfeit goods or services Chapter 113 (1) in section 2318(b)(2), by striking section 2320(e) section 2320(f) (2) in section 2320— (A) in subsection (a), by striking paragraph (4) and inserting the following: (4) traffics in a drug and knowingly uses a counterfeit mark on or in connection with such drug, ; (B) in subsection (b)(3), in the matter preceding subparagraph (A), by striking counterfeit drug drug that uses a counterfeit mark on or in connection with the drug (C) in subsection (f), by striking paragraph (6) and inserting the following: (6) the term drug 21 U.S.C. 321 .

Summary: (This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.) Transnational Drug Trafficking Act of 2015 (Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence. Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported. In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States. (Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."
Silver Star Service Banner Day Act


Summary: (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) Silver Star Service Banner Day Act (Sec. 3) This bill designates May 1 as Silver Star Service Banner Day.
Special Needs Trust Fairness Act of 2015


Summary: (This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.) Special Needs Trust Fairness Act of 2015 (Sec. 2) This bill amends title XIX (Medicaid) of the Social Security Act with respect to the treatment of revocable trusts for the benefit of an individual for purposes of meeting income requirements for Medicaid coverage. Extends the supplemental needs trust exemption from treatment of a trust as resources available to the individual to supplemental needs trusts for Medicaid beneficiaries established by those beneficiaries.
Ensuring Patient Access and Effective Drug Enforcement Act of 2016


Summary: (This measure has not been amended since it was reported to the Senate on February 11, 2016. The summary of that version is repeated here.) Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (Sec. 2) This bill amends the Controlled Substances Act to define phrases related to the Drug Enforcement Administration's (DEA's) authority to register manufacturers, distributors, and dispensers of controlled substances. Currently, the DEA registers a controlled substances manufacturer, distributor, or dispenser if it is in the public interest after considering certain factors, including factors relevant to and consistent with the public health and safety. This bill defines "factors as may be relevant to and consistent with the public health and safety" to mean factors relevant to and consistent with the specified purposes of the Controlled Substances Act. Additionally, current law allows the DEA to immediately suspend a registration to prevent imminent danger to the public health and safety. This bill defines "imminent danger to the public health and safety" to mean an immediate threat of death, serious bodily harm, or abuse of a controlled substance due to a registrant's failure to maintain effective controls against diversion. The bill revises and expands the required elements of an order to show cause issued by the DEA before it denies, revokes, or suspends a registration for a Controlled Substances Act violation. An order to show cause must specifically state the legal basis for the action and notify the registrant of the opportunity to submit a corrective action plan. (Sec. 3) The Food and Drug Administration, the Substance Abuse and Mental Health Services Administration, the Agency for Research and Quality, and the Centers for Disease Control and Prevention, in coordination with the DEA, must report to Congress on: obstacles to legitimate patient access to controlled substances; diversion of controlled substances; how collaboration between law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances; the availability of and gaps in medical education, training opportunities, and comprehensive clinical guidance for pain management and opioid prescribing; enhancements to prescription drug monitoring programs; and improvements to prescription opioid reporting requirements.
Secret Science Reform Act of 2015

To prohibit the Environmental Protection Agency from proposing, finalizing, or disseminating regulations or assessments based upon science that is not transparent or reproducible. 1. Short title This Act may be cited as the Secret Science Reform Act of 2015 2. Data transparency Section 6(b) of the Environmental Research, Development, and Demonstration Authorization Act of 1978 ( 42 U.S.C. 4363 (b) (1) The Administrator shall not propose, finalize, or disseminate a covered action unless all scientific and technical information relied on to support such covered action is— (A) the best available science; (B) specifically identified; and (C) publicly available online in a manner that is sufficient for independent analysis and substantial reproduction of research results. (2) Nothing in the subsection shall be construed as— (A) requiring the Administrator to disseminate scientific and technical information; or (B) superseding any nondiscretionary statutory requirement. (3) In this subsection— (A) the term covered action (B) the term scientific and technical information (i) materials, data, and associated protocols necessary to understand, assess, and extend conclusions; (ii) computer codes and models involved in the creation and analysis of such information; (iii) recorded factual materials; and (iv) detailed descriptions of how to access and use such information. (4) The Administrator shall carry out this subsection in a manner that does not exceed $1,000,000 per fiscal year, to be derived from amounts otherwise authorized to be appropriated. .

Summary: Secret Science Reform Act of 2015 (Sec. 2) This bill amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to prohibit the Environmental Protection Agency (EPA) from proposing, finalizing, or disseminating a covered action unless all scientific and technical information relied on to support such action is the best available science, specifically identified, and publicly available in a manner sufficient for independent analysis and substantial reproduction of research results. A &quot;covered action&quot; includes a risk, exposure, or hazard assessment, criteria document, standard, limitation, regulation, regulatory impact analysis, or guidance. The EPA must carry out the bill in a manner that does not exceed $1 million per fiscal year.
RESPONSE Act of 2016


Summary: RESPONSE Act of 2016 (Sec. 2) This bill amends the Homeland Security Act of 2002 to direct the Federal Emergency Management Agency (FEMA) to establish the Railroad Emergency Services Preparedness, Operational Needs, and Safety Evaluation (RESPONSE) Subcommittee of the National Advisory Council. The RESPONSE Subcommittee shall develop recommendations for improving emergency responder training and resource allocation for hazardous materials (hazmat) incidents involving railroads after evaluating the following topics: the quality and application of training for state and local emergency responders related to rail hazmat incidents, including training for emergency responders serving small communities near railroads; the availability and effectiveness of federal, state, local, and nongovernmental funding levels related to training emergency responders for rail hazmat incidents, including emergency responders serving small communities near railroads; and the strategy for integrating commodity flow studies, mapping, and rail and hazmat databases for state and local emergency responders and increasing the rate of access to the individual responder in existing or emerging communications technology. The RESPONSE Subcommittee shall terminate within 90 days after the council submits a report approving the RESPONSE Subcommittee recommendations.
Small Business Investment Capital Company Act of 2015

To amend the Small Business Investment Act of 1958 to provide for increased limitations on leverage for multiple licenses under common control. 1. Short title This Act may be cited as the Small Business Investment Capital Company Act of 2015 2. Increased limitations on leverage for multiple licenses under common control Section 303(b)(2) of the Small Business Investment Act of 1958 ( 15 U.S.C. 683(b)(2)(B) $225,000,000 $350,000,000

Summary: Small Business Investment Company Capital Act of 2015 (Sec. 2) Amends the Small Business Investment Act of 1958 to increase from $225 million to $350 million the maximum amount of outstanding leverage to be made available by the Small Business Administration to two or more commonly controlled small business investment companies not under capital impairment.
Federal Vehicle Repair Cost Savings Act of 2015


Summary: (This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)Federal Vehicle Repair Cost Savings Act of 2015 (Sec. 3) Defines "remanufactured vehicle component" as a vehicle component (including an engine, transmission, alternator, starter, turbocharger, steering, or suspension component) that has been returned to same-as-new, or better, condition and performance by a standardized industrial process that incorporates technical specifications (including engineering, quality, and testing standards) to yield fully warranted products. (Sec. 4) Directs the head of each federal agency to: (1) encourage the use of remanufactured vehicle components to maintain federal vehicles if using such components reduces the cost of maintaining such vehicles while maintaining quality; and (2) not encourage the use of remanufactured vehicle components if using such components does not reduce the cost of maintenance, lowers the quality of vehicle performance,&nbsp;or delays the return to service of a vehicle.
Improving Access to Emergency Psychiatric Care Act


Summary: (This measure has not been amended since it was passed by the House on November 16, 2015. The summary of that version is repeated here.) Improving Access to Emergency Psychiatric Care Act (Sec. 2) This bill amends the Patient Protection and Affordable Care Act to revise the length of the emergency psychiatric demonstration project under title XIX (Medicaid) of the Social Security Act that is currently limited to three years. Participation in the demonstration project shall be extended through FY2016 for any requesting states selected for eligibility to participate on or before March 13, 2012, if the Department of Health and Human Services (HHS) determines, and the Centers for Medicare &amp; Medicaid Services (CMS) certify, that a state's participation is projected not to increase net Medicaid program spending. An additional extension through December 31, 2019, may be granted to a state, and the number of states eligible to participate may be expanded through December 31, 2019, if the same fiscal criteria are met. HHS shall review annually each participating state's demonstration project expenditures to ensure budget neutrality. If a state's net programming spending has increased as a result of its participation in the project, HHS shall treat the excess expenditures as an overpayment under Medicaid. This bill also revises certain limitations on federal funding. HHS must submit recommendations to Congress: (1) first on whether the demonstration project should be continued after September 30, 2016, (2) whether it should be expanded to additional states, (3) subsequently on whether it should be permanently continued after December 31, 2019, in one or more states, and (4) finally on whether the demonstration project should be expanded (including on a nationwide basis). $100,000 shall be available for the project from unobligated balances of amounts available in the CMS Program Management account.
Rural Community Hospital Demonstration Extension Act of 2015

To amend title XVIII of the Social Security Act to provide for a five-year extension of the rural community hospital demonstration program, and for other purposes. 1. Short title This Act may be cited as the Rural Community Hospital Demonstration Extension Act of 2015 2. Five-year extension of the rural community hospital demonstration program (a) Extension Section 410A of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 ( Public Law 108–173 42 U.S.C. 1395ww Public Law 111–148 (1) in subsection (a)(5), by striking 5-year extension period 10-year extension period (2) in subsection (g)— (A) in the subsection heading, by striking Five-Year Ten-Year (B) in paragraph (1), by striking additional 5-year additional 10-year (C) by striking 5-year extension period 10-year extension period (b) Change in timing for report Subsection (e) of such section 410A is amended by striking Not later than 6 months after the completion Not later than 2 years prior to the completion

Summary: Rural Community Hospital Demonstration Extension Act of 2015 This bill amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, as amended by the Patient Protection and Affordable Care Act, to extend the period of the Medicare rural community hospital demonstration program from 5 to 10 years. The Department of Health and Human Services (HHS) shall allow certain rural community hospitals participating in the demonstration program as of December 30, 2014, to continue during the second five years of the 10-year extension period. HHS shall solicit applications to select up to the maximum number of additional rural community hospitals located in any state to participate in this demonstration program for the second five years of the ten-year extension period without exceeding the applicable limitation (30). In determining which applicant rural community hospitals to select for participation in the demonstration program, HHS: shall give priority to hospitals located in one of the 20 states with the lowest population densities; and may consider closures of hospitals located in rural areas in the state in which the hospital is located during the 5-year period immediately preceding the enactment of this Act, as well as the population density of the state.
Federal Improper Payments Coordination Act of 2015


Summary: (This measure has not been amended since it was passed by the Senate on July 28, 2015. The summary of that version is repeated here.) Federal Improper Payments Coordination Act of 2015 (Sec. 2) Amends the Improper Payments Elimination and Recovery Improvement Act of 2012 to extend the availability of the Do Not Pay Initiative to states, any contractor, subcontractor, or agent of a state, and the judicial and legislative branches of the United States. Authorizes the Office of Management and Budget (OMB) to issue guidance for establishing privacy and other requirements for incorporation into Do Not Pay Initiative access agreements with states and judicial and legislative branches. (Sec. 3) Modifies such Act to require each federal agency to review the death records maintained by the Social Security Administration (SSA) (currently, the Death Master File of SSA). Directs the Departments of Defense and State to establish a procedure for submitting information on the deaths of individuals to federal agencies promptly and on a regular basis. Requires the OMB and the heads of other relevant governmental entities to issue guidance on the implementation of the Do Not Pay Initiative to the Department of the Treasury and each agency and component of an agency: (1) that operates or maintains a database of information; or (2) for which the OMB determines improved data matching would be relevant, necessary, or beneficial. (Sec. 4) Directs Treasury to submit a report to Congress that describes: (1) data analytics performed as part of the Do Not Pay Business Center operated by Treasury, (2) metrics used in determining whether analytic and investigatory efforts have reduced improper payments or awards, and (3) the target dates for implementing the data analytics operations.
Water Resources Research Amendments Act of 2015


Summary: (This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.) Water Resources Research Amendments Act of 2015 (Sec. 2) Amends the Water Resources Research Act of 1984 to: (1) declare that additional research is required into increasing the effectiveness and efficiency of new and existing treatment works through alternative approaches, including non-structural alternatives, decentralized approaches, energy use efficiency, water use efficiency, and actions to extract energy from wastewater; (2) require each water resources research and technology institute to arrange for research that fosters the exploration of new ideas that expand understanding of water resources (currently, of water-related phenomena); (3) direct the Department of the Interior to report to specified congressional committees annually on each institute's compliance with matching fund requirements and provisions permitting the use of funds only to reimburse direct cost expenditures incurred for the conduct of the water resources research program; and (4) authorize appropriations for such institutes through FY2020.
Rafael Ramos and Wenjian Liu National Blue Alert Act of 2015


Summary: (This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.) Rafael Ramos and Wenjian Liu National Blue Alert Act of 2015 (Sec. 3) Directs the Attorney General to: (1) establish a national Blue Alert communications network within the Department of Justice (DOJ) to issue Blue Alerts through the initiation, facilitation, and promotion of Blue Alert plans for the dissemination of information received as a Blue Alert, in coordination with states, local governments, and law enforcement agencies; and (2) assign an existing DOJ officer to act as the national coordinator of the network. Defines &quot;Blue Alert&quot; as information sent through the network relating to: (1) the serious injury or death of a law enforcement officer in the line of duty, (2) an officer who is missing in connection with the officer's official duties, or (3) an imminent and credible threat that an individual intends to cause the serious injury or death of a law enforcement officer. (Sec. 4) Sets forth the duties of the national coordinator, including: providing assistance to states and local governments that are using Blue Alert plans; establishing voluntary guidelines for states and local governments to use in developing such plans; developing protocols for efforts to apprehend suspects; working with states to ensure appropriate regional coordination of various elements of the network; establishing an advisory group to assist states, local governments, law enforcement agencies, and other entities in initiating, facilitating, and promoting Blue Alert plans; acting as the nationwide point of contact for the development of the network and the regional coordination of Blue Alerts through the network; and determining what procedures and practices are in use for notifying law enforcement and the public of a Blue Alert and which procedures and practices are effective and do not require the expenditure of additional resources to implement. Requires the guidelines to: (1) provide that appropriate information relating to a Blue Alert is disseminated to officials of law enforcement, public health, and other agencies; (2) provide mechanisms that ensure that Blue Alerts comply with all applicable federal, state, and local privacy laws and regulations; and (3) include standards that specifically provide for the protection of the civil liberties of law enforcement officers and their families. Directs the coordinator to report annually on the coordinator's activities and the effectiveness and status of the Blue Alert plans that are in effect or being developed.